Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p

References

• Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21(Suppl 2):S37–43.
   PubMed Web of Science ®Google Scholar
• Capdevila J, Mayor R, Mancuso FM, et al. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol. 2018;29(6):1454–1460.
   PubMed Web of Science ®Google Scholar
• Amit M, Na’ara S, Francis D, et al. Post-translational regulation of radioactive iodine therapy response in papillary thyroid carcinoma. J Natl Cancer Inst. 2017;109(12). DOI:10.1093/jnci/djx092.
   PubMedGoogle Scholar
• Aashiq M, Silverman DA, Na’ara S, et al. Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies. Cancers (Basel). 2019;11(9):1382.
   PubMed Web of Science ®Google Scholar
• Yang T, Zhai H, Yan R, et al. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line. Braz J Med Biol Res. 2018;51(6):e7046.
   PubMed Web of Science ®Google Scholar
• Li HM, Yang H, Wen DY, et al. Overexpression of LncRNA HOTAIR is associated with poor prognosis in thyroid carcinoma: a study based on TCGA and GEO data. Horm Metab Res. 2017;49(5):388–399.
   PubMed Web of Science ®Google Scholar
• Xie Q, Lin S, Zheng M, et al. Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p. Biochem Cell Biol. 2019;97(2):100–108.
   PubMedGoogle Scholar
• Wang H, Zhang M, Sun G. Long non-coding RNA NEAT1 regulates the proliferation, migration and invasion of gastric cancer cells via targeting miR-335-5p/ROCK1 axis. Pharmazie. 2018;73(3):150–155.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin T, Shen H, et al. Identification of long non-coding RNA expression profiles and co-expression genes in thyroid carcinoma based on the cancer genome atlas (TCGA) database. Med Sci Monit. 2019;25:9752–9769.
   PubMed Web of Science ®Google Scholar
• Liu H, Deng H, Zhao Y, et al. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res. 2018;37(1):279.
   PubMedGoogle Scholar
• Luzón-Toro B, Fernández RM, Martos-Martínez JM, et al. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Sci Rep. 2019;9(1):14374.
   PubMedGoogle Scholar
• Zhang H, Cai Y, Zheng L, et al. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 2018;233(10):6638–6648.
   PubMed Web of Science ®Google Scholar
• Luo Y, Hao T, Zhang J, et al. MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1. Int J Mol Med. 2019;44(3):1172–1182.
   PubMed Web of Science ®Google Scholar
• Chen MY, Fan K, Zhao LJ, et al. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson’s disease. Bioengineered. 2021;12(1):708–719.
   PubMed Web of Science ®Google Scholar
• An Q, Zhou Z, Xie Y, et al. Knockdown of long non-coding RNA NEAT1 relieves the inflammatory response of spinal cord injury through targeting miR-211-5p/MAPK1 axis. Bioengineered. 2021;12(1):2702–2712.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhang C, Yao H, et al. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Mol Cancer. 2018;17(1):105.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang P, Cui Y. Long noncoding RNA NEAT1 inhibits the acetylation of PTEN through the miR-524-5p /HDAC1 axis to promote the proliferation and invasion of laryngeal cancer cells. Aging (Albany NY). 2021;13(22):24850–24865.
   PubMedGoogle Scholar
• Nguyen MT, Lin CH, Liu SM, et al. miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma. Neoplasia. 2020;22(12):789–799.
   PubMed Web of Science ®Google Scholar
• Li X, Li Z, Zhu Y, et al. miR-524-5p inhibits angiogenesis through targeting WNK1 in colon cancer cells. Am J Physiol Gastrointest Liver Physiol. 2020;318(4):G827–G839.
   PubMed Web of Science ®Google Scholar
• Ye WC, Gao L, Huang J, et al. Suppressed Kruppellike factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma. Mol Med Rep. 2014;10(4):2087–2092.
   PubMed Web of Science ®Google Scholar
• Wu DM, Wang S, Wen X, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018;9(10):947.
   PubMedGoogle Scholar
• Sun Z, Guo X, Zang M, et al. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis. J Cell Physiol. 2019;234(2):1336–1345.
   PubMed Web of Science ®Google Scholar
• Feng Z, Chen R, Huang N, et al. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Life Sci. 2020;244(117298):117298.
   PubMedGoogle Scholar
• Zeng W, Lin Y, Lin H, et al. Silencing NEAT1 suppresses thyroid carcinoma via miR-126/NEAT1/VEGFA axis. Front Biosci (Landmark Ed). 2020;25:564–576.
   PubMed Web of Science ®Google Scholar
• Liu C, Feng Z, Chen T, et al. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 2019;18(2):167–203.
   PubMed Web of Science ®Google Scholar
• Liu X, Liang Y, Song R, et al. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer. 2018;17(1):90.
   PubMedGoogle Scholar
• Zhao D, Hou Y. Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis. Bioengineered. 2022;13(1):1828–1837.
   PubMed Web of Science ®Google Scholar
• Liu GH, Liu YH, Yang Z, et al. MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells. Oncol Lett. 2016;11(3):1926–1932.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang W, Yan W, et al. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Carcinogenesis. 2012;33(11):2276–2282.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen X, Lin T, et al. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways. J Cell Physiol. 2019;234(10):18382–18391.
   PubMed Web of Science ®Google Scholar
• Hu X, Chen M, Li Y, et al. Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma. Oncol Rep. 2019;41(2):1091–1100.
   PubMed Web of Science ®Google Scholar
• Hu XM, Lin T, Huang XY, et al. ID1 contributes to cell growth invasion and migration in salivary adenoid cystic carcinoma. Mol Med Rep. 2017;16(6):8907–8915.
   PubMed Web of Science ®Google Scholar